Energesis Pharmaceuticals logo — Pioneering a novel pathway in treating obesity and diabetes...

Energesis Pharmaceuticals

Pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure.

Founded 2009 2 employees Grant Total: $150.00K Biotechnology, Health and Wellness

General Information

Company Name Energesis Pharmaceuticals
Founded Year 2009
Founders / Decision Makers
Team member
Employees 2
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Energesis Pharmaceuticals. To contact Energesis Pharmaceuticals, visit energesispharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Energesis Pharmaceuticals

Energesis Pharmaceuticals is a biotechnology startup that was founded in 2009. The company is focused on pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure. Unlike traditional approaches that mainly tackle the intake side of weight management, Energesis Pharmaceuticals is dedicated to specifically addressing the expenditure aspect of the body's energy. Their innovative strategy has attracted $100.00K in grant investment from MassVentures as of 30 June 2021. The company is operating in the Biotechnology and Health and Wellness industries, seeking to discover and develop treatments for obesity, diabetes, and related metabolic conditions.

Taxonomy: biopharmaceutical, obesity treatment, diabetes treatment, metabolic conditions, drug discovery, energy expenditure, weight management, innovative drugs, metabolic diseases, pharmaceutical company

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $100.00K 1
MassVentures
30 Jun 2021
Grant $50.00K 1
MassChallenge
22 Oct 2010

Energesis Pharmaceuticals Alternatives & Competitors

Energesis Pharmaceuticals vs
Phyteau, Inc.
Phyteau, Inc. United States

Designed by Nature, Delivered by Science: A new class of incretin therapy for diabetes, obesity and...

Seed
3 employees
Biotechnology, Food and Beverage
Energesis Pharmaceuticals vs

Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell dru...

Venture round
9 employees
Biotechnology, Health Care
Energesis Pharmaceuticals vs
BioAge Labs
BioAge Labs United States

We are harnessing the biology of human aging to develop novel targets and therapies for metabolic di...

Series D
99 employees
Biopharma, Biotechnology

FAQ About Energesis Pharmaceuticals

Pioneering a novel pathway in treating obesity and diabetes by enhancing the body's energy expenditure.
Energesis Pharmaceuticals was founded in 2009.
Energesis Pharmaceuticals operates in Biotechnology and Health and Wellness. Its work centres on biopharmaceutical, obesity treatment, diabetes treatment and metabolic conditions.
Energesis Pharmaceuticals has approximately 2 employees.
Energesis Pharmaceuticals has completed 2 funding rounds, raising a total of $150.00K. The latest funding stage is Grant.
Top alternatives and competitors to Energesis Pharmaceuticals include Phyteau, Inc., Diasome Pharmaceuticals, Inc., BioAge Labs, Rezolute, Inc., Lisata Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Energesis Pharmaceuticals and Phyteau, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Energesis Pharmaceuticals, https://bouncewatch.com/company/energesis-pharmaceuticals, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes